Skip to main content

Table 2 Descriptive statistics (median and range) and Wilcoxon signed rank test of the biomarkers measured on Day 1 and Day 3 in the stroke patients

From: Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients

 

Day 1

Day 3

Z

P <

Plasma TNF-α, pg/mL

0.7 (0-12)

0.9 (0-32)

-1.836

0.07

Plasma IL-6, pg/mL

9 (0-58)

8 (0.4-100)

-0.628

0.5

Plasma ET-1, pg/mL

7 (7-18)

9 (5-17)

-0.968

0.3

Serum E-selectin, ng/mL

61 (36-77)

52 (43-65)

-2.062

0.04*

Serum ICAM-1, ng/mL

233 (14-403)

200 (18-293)

-0.157

0.9

Serum VCAM-1, ng/mL

642 (427-1125)

655 (47-1165)

-1.098

0.3

Serum MMP-9, ng/mL

398 (0-1384)

438 (292-542)

-0.178

0.8

Serum TIMP-1, ng/mL

264(195-540)

285 (153-376)

-1.067

0.3

MMP-9/TIMP-1

1.3 (0-4.8)

1.4 (0.2-5.8)

-0.267

0.8

  1. *P < 0.05